--- title: "Patient: citation metrics, topics and most-cited papers" description: "Patient has a 2-year mean citedness of 3.60 and an h-index of 70 in OpenAlex, #12 of 28 tracked health economics and policy journals by citedness. In 2025 it published 71 papers, and its papers received 3,232 citations." url: https://scholar4ai.com/journals/patient markdown_url: https://scholar4ai.com/journals/patient.md license: CC BY-NC 4.0 (https://creativecommons.org/licenses/by-nc/4.0/) share_text: "Patient has a 2-year mean citedness of 3.60 and an h-index of 70 in OpenAlex, #12 of 28 tracked health economics and policy journals by citedness. In 2025 it published 71 papers, and its papers received 3,232 citations. (as of 2026-11-03)" data_url: https://scholar4ai.com/data/rankings.json updated: 2026-11-03T18:03:37+09:00 window: 2026-10-05 to 2026-11-03 source: OpenAlex (CC0) --- # Patient - 1 paper in the last 7 days - category: Health Economics and Policy - publisher: Adis, Springer Healthcare - ISSN 1178-1653 - Journal website: https://www.springer.com/journal/40271 - ISSN portal: https://portal.issn.org/resource/ISSN/1178-1653 - OpenAlex: https://openalex.org/S12699048 Back to the ranking: https://scholar4ai.com/rankings/journals.md Rankings of Health Economics and Policy: [Health Economics and Policy dashboard](https://scholar4ai.com/categories/health-economics-and-policy.md) · [Health Economics and Policy journal rankings by citations](https://scholar4ai.com/rankings/journal-metrics/health-economics-and-policy.md) · [Top health economics and policy institutions, 2023–2025](https://scholar4ai.com/rankings/institutions-by-year/health-economics-and-policy.md) · [Top funders of health economics and policy research](https://scholar4ai.com/rankings/funders/health-economics-and-policy.md) · [Companies in health economics and policy research](https://scholar4ai.com/rankings/companies/health-economics-and-policy.md) · [Open access in health economics and policy journals](https://scholar4ai.com/rankings/open-access/health-economics-and-policy.md) ## Key findings - Patient has a 2-year mean citedness of 3.60 and an h-index of 70 in OpenAlex, #12 of 28 tracked health economics and policy journals by citedness. - In 2025 it published 71 papers, and its papers received 3,232 citations. - Patient published 6 papers in the last 30 days (2026-10-05 to 2026-11-03), ranking #178 of 480 journals. - Leading institutions: Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal (1), Centre de recherche du CHU de Québec-Université Laval (1) and Université de Montpellier (1). - Countries: United States (3), United Kingdom (3) and Canada (1). - From Nov 2023 to Oct 2026, Patient published 6 papers (0 a month on average, by publication date in OpenAlex). - Its most frequent keywords over that period were “DPP-4 inhibitors” (1), “GLP-1 receptor agonists” (1) and “Quebec” (1). ## Citation metrics *Citation metrics (OpenAlex)* | Metric | Value | |---|---:| | 2-year mean citedness | 3.60 | | h-index | 70 | | i10-index | 578 | | Papers in OpenAlex | 1,005 | | Citations in OpenAlex | 26,234 | | Rank among tracked health economics and policy journals | [#12 of 28](https://scholar4ai.com/rankings/journal-metrics/health-economics-and-policy.md) | *Papers per year and the citations the journal's papers received that year (OpenAlex)* | Year | Papers | Citations received | |---|---:|---:| | 2026 (so far) | 53 | 2,323 | | 2025 | 71 | 3,232 | | 2024 | 59 | 3,279 | | 2023 | 55 | 2,849 | | 2022 | 46 | 2,961 | | 2021 | 77 | 2,623 | | 2020 | 85 | 2,066 | | 2019 | 51 | 1,569 | | 2018 | 64 | 1,344 | | 2017 | 75 | 1,152 | | 2016 | 58 | 854 | 2-year mean citedness is OpenAlex's count of citations per paper a journal published in the two previous years, an open counterpart to the journal impact factor (which counts only Web of Science citations); the h-index and i10-index cover all its papers. The figures come from OpenAlex (CC0) and are read again monthly. Official metrics such as the Journal Impact Factor (Clarivate) and CiteScore (Scopus) are licensed by their owners and not copied here; the publisher shows them on the journal's website. Journal website: https://www.springer.com/journal/40271 ## The last 36 months *Papers by publication date, Nov 2023 to Oct 2026* | Nov 23–Oct 24 | Nov 24–Oct 25 | Nov 25–Oct 26 | 36 months | |---:|---:|---:|---:| | 0 | 0 | 6 | 6 | *Most frequent keywords, Nov 2023 to Oct 2026* | # | Keyword | Papers | |---:|---|---:| | 1 | DPP-4 inhibitors | 1 | | 2 | GLP-1 receptor agonists | 1 | | 3 | Quebec | 1 | | 4 | acute leukemia | 1 | | 5 | caregiver burden | 1 | | 6 | chronic fatigue syndrome | 1 | | 7 | colorectal cancer screening | 1 | | 8 | continuity of care | 1 | | 9 | corrective feedback | 1 | | 10 | decision consistency | 1 | *Papers, newest first.* | Date | Title | Journal | Authors | Affiliations | |---|---|---|---|---| | 2026-10-28 | [Patients’ Preferences for Synchronous Teleconsultation with a General Practitioner in Primary Care in Quebec: A Discrete Choice Experiment](https://doi.org/10.1007/s40271-026-00852-z) | [Patient](https://scholar4ai.com/journals/patient.md) | Thomas G. Poder, Marc Henri N'Guessan, Hosein Ameri et al. | Université Laval; Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal; Centre de recherche du CHU de Québec-Université Laval; … | | 2026-10-16 | [Qualitative Exit Interviews to Characterize the Positive Treatment Experiences of Patients in the Phase III Trial of Orforglipron Versus Oral Semaglutide for the Treatment of Type 2 Diabetes](https://doi.org/10.1007/s40271-026-00847-w) | [Patient](https://scholar4ai.com/journals/patient.md) | Kristina Secnik Boye, Katelyn N. Cutts, Youna Zhao et al. | Eli Lilly (United States) | | 2026-10-16 | [Capturing the Lived Experiences of Informal Care in Acute Leukaemia: A Multinational Qualitative Study](https://doi.org/10.1007/s40271-026-00848-9) | [Patient](https://scholar4ai.com/journals/patient.md) | Samantha Nier, Claud Theakston, Priscila Radu et al. | Office Of Health Economics | | 2026-10-16 | [Educational Materials for Health-Related Discrete Choice Experiments: A Theory-Driven Approach](https://doi.org/10.1007/s40271-026-00850-1) | [Patient](https://scholar4ai.com/journals/patient.md) | Stella Maria Marceta, Huib Karel Tabbers, Bjorn Benny de Koning et al. | Erasmus University Rotterdam; University of Southampton; Arthritis UK; … | | 2026-10-15 | [Measures of Overall Illness Severity and Burden for ME/CFS: A Scoping Review](https://doi.org/10.1007/s40271-026-00849-8) | [Patient](https://scholar4ai.com/journals/patient.md) | Jada Cripe, Suvetha Ravichandran, Samantha Deditz et al. | DePaul University | | 2026-10-09 | [Correction: Women’s Treatment Preferences for Moderate to Severe Vasomotor Symptoms Associated with Menopause: Insights from the WARMER Study](https://doi.org/10.1007/s40271-026-00845-y) | [Patient](https://scholar4ai.com/journals/patient.md) | Sebastian Heidenreich, Tommaso Simoncini, Katelyn N. Cutts et al. | Thermo Fisher Scientific (United Kingdom); University of Pisa; Thermo Fisher Scientific (United States); … | ## Cite this page Scholar4AI. (2026). Patient. Journal and Conference Research Rankings. Retrieved November 3, 2026, from https://scholar4ai.com/journals/patient ```bibtex @misc{scholar4ai-journals-patient, author = {{Scholar4AI}}, title = {Patient}, year = {2026}, howpublished = {\url{https://scholar4ai.com/journals/patient}}, urldate = {2026-11-03}, note = {Journal and Conference Research Rankings; data from OpenAlex (CC0); licensed CC BY-NC 4.0} } ``` License: CC BY-NC 4.0 (https://creativecommons.org/licenses/by-nc/4.0/).